Patent ID: 7226949

Claim:
A method of treating and ameliorating epilepsy, seizure or electroconvulsive disorders in mammals which comprises administering a therapeutic effective amount to said mammal of the following therapeutic compound, including resolved enantiomers, diastereomers, salts, solvates and polymorphic froms thereof, having the following formula (I): wherein R 1 , R 2 , R 3 , and R 4 , are each independently selected from the group consisting of hydrogen, hydroxy, amino, phenyl, a substituted or unsubstituted C 1-10 alkyl, C 3-10 branched alkyl, a substituted or unsubstituted C 3-8 cycloalkyl, a substituted or unsubstituted arylalkyl, a substituted or unsubstituted C 1-10 alkoxyl and a substituted or unsubstituted C 1-10 acyl; and X is selected from the group consisting of —O—, —S—, —N(H)—, —Se—, —Si—, —CH═CH—, —C≡C—, —N═N—, —N═CH—, —CH═N—, —C(S)—, —N(H)S(O)—, —N(H)SO 2 —, —N(H)O—, —N(H)S—, —S(O)—, —SO 2 , —PO 4 —, —Si(O)—, —C(O)—, —CH 2 —, —CF 2 —, and a covalent bond.